Stonepine Capital Management
LKFT icon

Stonepine Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Stonepine Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-93,968
Closed -$2.36M – 70
2025
Q1 		$2.36M Sell
93,968
-106,032
-53% -$2.68M 2.3% 17
2024
Q4 		$5.5M Sell
200,000
-278,659
-58% -$7.77M 4.44% 4
2024
Q3 		$13.8M Sell
478,659
-6,341
-1% -$173K 8.71% 3
2024
Q2 		$12M Buy
485,000
+91,366
+23% +$2.59M 10.97% 4
2024
Q1 		$12.7M Buy
393,634
+131,764
+50% +$4.9M 10.05% 4
2023
Q4 		$10.6M Sell
261,870
-540,674
-67% -$19.9M 4.6% 7
2023
Q3 		$27.7M Buy
802,544
+119,880
+18% +$4.67M 9.21% 5
2023
Q2 		$27.8M Sell
682,664
-99,625
-13% -$4.06M 10.01% 4
2023
Q1 		$30.2M Buy
782,289
+587,453
+302% +$24.1M 10.14% 2
2022
Q4 		$8.65M Buy
+194,836
New +$8.2M 3.64% 9
2021
Q4 		– Sell
-244,205
Closed -$12.8M – 27
2021
Q3 		$12.8M Buy
+244,205
New +$14.5M 5.85% 4
2021
Q2 		– Sell
-10,000
Closed -$771K – 30
2021
Q1 		$771K Buy
+10,000
New +$921K 0.42% 27

Other funds holding LKFT

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Tang Capital Management
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Madison Avenue Partners
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Prosight Management
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Segall Bryant & Hamill
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
DME Capital Management
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Stonepine Capital Management's LKFT Position: Q2 2025 in Review

Stonepine Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2025, closing a stake of 93,968 shares — an estimated $2.36M sold.

Stonepine Capital Management first reported a position in LKFT in Q1 2021 and held it in 12 quarters. The position peaked at $30.2M in Q1 2023. 85 funds tracked by Wall St. Rank hold LKFT as of Q2 2025.

  • Stonepine Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Stonepine Capital Management sold 93,968 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2025, an estimated $2.36M.
  • Stonepine Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 12 quarters.
  • Stonepine Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $30.2M in Q1 2023.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2025.

Based on Stonepine Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.